Advanced Empty Capsule Market

Key Points Covered in Advanced Empty Capsules Market Study

• Market estimates and forecast 2015-2031
• Key drivers and restraints impacting market growth
• Segment-wise, Country-wise, and Region-wise Analysis
• Competition Mapping and Benchmarking
• Brand share and Market Share Analysis
• Key Product Innovations and Regulatory Climate
• COVID-19 Impact on Advanced Empty Capsules Sales and How to Navigate
• Recommendation on Key Winning Strategies

2016-2020 Advanced Empty Capsule Market Outlook Compared to 2021-2031 Forecast

Driven by increasing demand for customized capsules and an increase in nutraceutical consumption, the advanced empty capsules market will register 6.2% CAGR during 2016-2020.

The per capita spending on healthcare is increasing globally. According to the World Health Organization (WHO), the total healthcare spending in the U.S. was US$ 3.6 trillion in 2018, which grew by 4.6% as compared to 2017.

Moreover, the demand for vegetarian-based capsules has increased in nutraceutical and pharmaceutical companies as they seek to avoid manufacturing issues arising from gelatin alternatives. As a result, vegetarian-based capsules are expected to witness significant growth over the forecast period.

Rising demand for halal-certified products from countries with Muslim populations is expected to fuel demand. Pharmaceutical manufacturers are shifting to producing halal-certified products to leverage opportunities arising from this demand.  Top pharma companies are focusing on expanding their geographical presence.

For instances, In Feb 2020, Qualicaps® Europe, S.A.U. expanded its presence in the South Asia region. According to the FMI report, the market is set to grow at an 8% CAGR between 2021 and 2031.

What is the Impact of Tech Advancements on the Market?

Previously, hard gelatin capsules were used to fill dry powders, pellets, and granular dosage forms. The trend has changed after the introduction of new technologies such as fusion of caps and parts of empty capsules and seals.

In health and nutritional applications, lipid-based formulations are used to increase bioavailability, avoid bitter taste and odor, along with a combination of therapy and delayed-release formulation.

These novel technologies for filling liquids and semi-solids into empty capsules in pharmaceuticals, cosmeceuticals, and nutraceutical companies is expected to drive revenues over the forecast period.

Several leading players are focusing on launch of advanced technologies. For instance, Capsugel Company developed Licaps®, an innovative technology that allows the sealing of liquid fresh pure organic ingredients in hard gelatin capsules.

It optimizes capsule disintegration, making it ideal for products requiring fast release, as an alternative to liquid medications.

What is the Impact of the COVID-19 Crisis on the Market?

The COVID-19 pandemic has hampered supply and demand for pharmaceutical products. Some medications have witnessed a slump, as patients are unable to access medications owing to transportation issues.

The increased demand for select over-the-counter (OTC) medication is likely to influence market developments.

Despite the difficult situation of the pandemic, longer-term opportunities in drug development and research to overcome bioavailability will have a positive impact on the market.

Country-wise Insights

How Big is the Opportunity for Russia?

Europe is predicted to remain one of the most attractive markets during the forecast period, according to Future Market Insights. Russia is expected to grow during the forecast period with a CAGR of 7.3% in 2021-2031.

The high demand for vitamin supplements is expected to drive the market in Russia. Vitamins are more stable and effective with the help of capsules. Empty capsule manufacturers are developing new, customized offerings to fulfil the requirements of vitamin efficacy and safety.

How is the Demand for Advanced Empty Capsules in the U.K. Set to Fare?

Demand in the U.K. market is expected to rise at nearly 5.2% CAGR over the forecast period. The U.K. has witnessed a high level of healthcare spending in Europe.

Due to rising research activities, the presence of several major players, are creating attractive opportunities for this market in the country.

The U.K. healthcare system is backed by well-developed infrastructure and is largely supported by the government creating a conducive environment for long term growth.

Why is Innovation Key to Succeed in the German Pharmaceutical Market?

Germany is one of the world's topmost manufacturers of pharmaceuticals. By 2031, it is expected account for over 25.8% of the market share within Europe. Technological advancement is the main focus of manufacturers in this country.

Empty capsule manufacturers are taking responsibility to provide unique offerings, which are more versatile and convenient for pharmaceutical, nutraceutical and cosmeceutical applications. Top companies in the German market are developing innovative products in these areas.

For instance, in March 2021, ACG, a leading supplier of fully integrated solutions to the global pharmaceutical and nutraceutical industry, announced its new ACGcaps™ NTone and ACGcaps™ TSafe range of capsules for the nutraceutical market.

ACGcaps™ TSafe is a range of capsules that are free of titanium dioxide and are available in different options for gelatin and HPMC range.

What is Driving Sales in India?

In 2021, India will account for over 60.7% of sales in South Asia. Government initiatives undertaken to give quality and affordable healthcare are anticipated to supplement the development of the Indian market.

Asian countries can exhibit steady regional growth due to an increase in favourable government initiatives such as the launch of National Health Insurance and relaxation in custom duties, in the untapped markets of South Asia. The high demand for HPMC capsules along with high ASP has led to dynamic growth of this segment.

Various measures taken by governments and radiotherapy service providers, such as outcome-based pricing, benefit and risk sharing, price management, and competitive tendering, are driving this transition from a volume-based to a value-based scheme in India.

How Big is the Opportunity for Advanced Empty Capsules Market in Australia?

Australia is expected to grow at a CAGR of 12.1% over the forecast period. Cost-cutting initiatives to reduce the burden of healthcare, especially in developing economies is creating opportunities.

With the help of research and development new drug delivery systems drive growth in the long-term. Reducing the manufacturing cost is also a major concern for the pharmaceutical industry, which will potentially give a boost to the market in Australia.

For instance, in 2020, Capsugel launched Coni-Snap®, hard gelatin, sprinkle capsules specifically designed to meet the needs of a rapidly growing population that have difficulty swallowing. It is also available in HPMC.

Download a Comprehensive Report Snapshot

Category-wise Insights

What Drives the Demand for Oral Capsules?

Based on product type, oral capsules are holding the lead, accounting for nearly 89.8% of the market in 2021. These capsules can be produced for individual medications for a single patient, to provide specific doses and combinations to improve patient compliance. Hence, this is expected to increase demand.

Oral capsules are expected to remain the top choice for any patient since they are easy to get, easy to swallow, are cost-effective, and prevent delayed released gastric degradation. The trend to use hard gelatin capsules to provide patients with therapy is expected to increase the use of empty capsules.

Why are Vegetarian-based Empty Capsules Gaining Traction?

Based on raw material, vegetarian-based capsules are displaying fast growth with a CAGR of 10.7% over a forecast period of 2021-2031. Vegetarian-based capsules are adopted by both pharmaceutical as well as nutraceutical industries.

This can be attributed to the demand from vegans and vegetarians in addition to concerns over allergies. Additionally, cellulose is being used as an alternative to animal source products. Hence, a sudden increase in the demand for use of vegetarian capsules can be a great opportunity for manufacturers in future.

Which is More Preferred Advanced Empty Capsules Size?

The size "0" capsules segment is estimated to account for the largest revenue share of 19.3% in 2021 owing to the rising adoption of oral capsules.

"0" Size capsules hold up to 500 mg of drugs and most of pharmaceutical dosages are produced in volumes of 500mg. The rise in the spending of healthcare, patient compliance, and a high adoption rate of a new drug delivery system, is expected to support the interest in the market during the forecast period.

Why Do Pharmaceutical Applications Account for Maximum Advanced Empty Capsules Sales?

The pharmaceutical segment is expected to contribute a maximum revenue share of 62.5% in 2021. Globally this market is rising due to empty capsules and are utilized in the production of various pharmaceutical products.

Nowadays, new pharma startups are started and are growing strongly due to government initiatives and spending. Government spending on healthcare is the highest amongst richer countries and contributes about 60% of total healthcare expenditure. The total healthcare expenditure is expected to rise globally from 2019 to 2023 at a CAGR of 5%.

Competitive Landscape

their product manufacturing to address the demand of an expanding patient pool.

• For instance, Medi-Caps Limited has pioneered many advanced features in product development such as “Pearlz Capsules” (Metallic Colored) as well as Python Printing & Li-Fill Caps
• On June 21, 2019, Embocaps® was developed by the Sheung brand. The Embocaps®LP+ is a hard capsule specifically designed to hold liquids and fine powders. The Embocaps® LP+ is available in multiple gelatin, vegetarian and relayed release formulations.

Some of the leading companies operating in the market are:

• Capsugel (Lonza)
• ACG Worldwide
• Medi-Caps Limited
• Sunil Healthcare Limited
• Roxlor LLC
• CapsCanada Corporation
• Suheung Co., Ltd.
• Bright Pharma Caps
• STERIS Plc
• Fuji Capsule Co. Ltd.
• QUALICAPS

*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.

Scope of Report

Enquiry Before Buying

• Is this research conducted by Future Market Insights?

  Yes, the research has been conducted by expert analysts of Future Market Insights, through a combination of primary research and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

• What research methodology is followed by Future Market Insights?

  Future Market Insights follows a methodology that encompasses the demand-side assessment of the market and triangulates the same through supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions. Request a detailed methodology.

• Who are the respondents for primary research?

  Future Market Insights speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

• What are the sources of secondary research?

  Future Market Insights conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

• Is a sample of this report available for evaluation?

  Yes, you can request a sample, and it will be sent to you through email.

• How can I buy this report?

  Future Market Insights provides a secure online payment system to buy reports seamlessly. You can buy the report securely and safely.

Advanced Empty Capsule Market by Category

By Product Type:

• Oral Capsules
  • Dry formulation
    • Immediate-release capsules
      • Gelatin
      • HPMC
      • Starch
      • Pullulan
    • Delayed-release capsules
      • Time delayed release capsules
        • Gelatin
        • HPMC
      • Acid-resistant capsules
        • Gelatin
        • HPMC
        • HPMCP
      • Enteric capsules
        • Gelatin
        • HPMC
        • HPMC-AS
  • Liquid formulation
    • Gelatin
    • HPMC
    • Starch
    • Pullulan
• Inhalation Capsules
  • Gelatin
  • HPMC
  • Starch
  • Pullulan

By Raw Material:

• Animal Source
  • Contract Type-A (Pork Skin
  • Type-B Gelatin (Animal Bones & Calf Skin)
  • Fish Bone Gelatin
• Vegetarian-based
  • Hydroxy Propyl Methyl Cellulose (HPMC)
  • Starch
  • Pullulan

By Capsules Size:

• Size "000" Capsules
• Size "00" Capsules
• Size "0" Capsules
• Size "1" Capsules
• Size "2" Capsules
• Size "3" Capsules
• Size "4" Capsules
• Size "5" Capsules

By End User:

• Pharmaceutical
• Nutraceutical & Cosmetic
• CROs
• CMOs

By Region:

• Europe
• South Asia
• Middle East
• Africa
• Pacific